Anbio Biotechnology Class A Ordinary Shares (NNNN) — Cash Flow-to-Debt Ratio
Anbio Biotechnology Class A Ordinary Shares (NNNN) has a Cash Flow-to-Debt Ratio of 0.93x as of December 2024, meaning its operating cash flow of $1.60 Million could theoretically repay 1% of its total liabilities ($1.73 Million) in one year. Check cash flow reinvestment rate of Anbio Biotechnology Class A Ordinary Sha to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Anbio Biotechnology Class A Ordinary Shares Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Anbio Biotechnology Class A Ordinary Shares across 5 annual periods. Also explore Anbio Biotechnology Class A Ordinary Sha assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Anbio Biotechnology Class A Ordinary Shares (2021–2025)
Year-by-year debt coverage analysis for Anbio Biotechnology Class A Ordinary Shares. For market capitalisation and broader financial context, see market value of Anbio Biotechnology Class A Ordinary Sha.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -76.72x | $-6.74 Million | $87.84K | ▼ -6481.0% |
| 2024 | 1.20x | $2.08 Million | $1.73 Million | ▲ +32.9% |
| 2023 | 0.90x | $898.37K | $993.06K | ▼ -71.3% |
| 2022 | 3.15x | $4.45 Million | $1.41 Million | ▲ +79.4% |
| 2021 | 1.76x | $4.18 Million | $2.38 Million | — |